Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silybum marianum for prevention and treatment of hepatotoxicity in children with ALL
IRCT2014080717325N2Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in chemical and drug induced liver injury (DILI) and acute lymphoblastic leukemia (ALL), sponsored by Ardabil University of Medical Sciences. Started Feb 2013; status: completed.
02
Drugs
silymarin
03
Conditions
chemical and drug induced liver injury (DILI)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT2014080717325N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014080717325N2.